The 2012 Spanish Hematology and Flow Cytometry Markets (Related Reports)

The 2012 Spanish Hematology and Flow Cytometry Markets


March 28, 2012
255 Pages - SKU: VPG3815862
License type:
PDF E-mail From Publisher      US $5,500.00
Global Site License Fulfilled by Publisher      US $11,900.00
The United States Market for In Vitro Diagnostic Tests
3/18/2014 | published by: Kalorama Information
The United States is the world’s largest in vitro diagnostics and nearly half of the global IVD market. While companies seek emerging markets for growth, most healthcare business is generated in the United States and  |  read more...
$3,995.00
Cervical Cancer Test Market & Patients - Pap Smear, HPV DNA, VIA – Test & Patients – Worldwide
4/1/2014 | published by: Renub Research
Cervical Cancer Test Market & Patients - Pap Smear, HPV DNA, VIA – Test & Patients – Worldwide Cervical Cancer Test Market Overview Cervical cancer is one of the deadliest cancers  |  read more...
$1,490.00
In-Vitro Diagnostics Market Outlook 2018
4/1/2014 | published by: RNCOS
In-Vitro Diagnostics Market Outlook 2018 Driven by factors, such as increasing prevalence of chronic diseases, rising demand for POCT and technological advancements in the global market, the IVD market is going through a very  |  read more...
$1,700.00
Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non Small Cell Lung Cancer and Others), Product (Inst
4/11/2014 | published by: MarketsandMarkets
Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non Small Cell Lung Cancer and Others), Product (Instruments and Consumables), End-Users  |  read more...
$4,650.00
Survival Strategies for the Global In Vitro Diagnostics Industry
4/10/2014 | published by: Frost & Sullivan
Survival Strategies for the Global In Vitro Diagnostics Industry While there is a positive outlook for global in vitro diagnostics (IVD), top companies face challenges such as slowing growth, increasing competition, and a changing business environment.  |  read more...
$1,500.00
Analytical Tool - Hematological Cancers
3/25/2014 | published by: BioSeeker Group AB
Analytical Tool - Hematological Cancers Analytical Tool – Hematological Cancers offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in R&D and business development in hematological cancers. It is at  |  read more...
$22,312.50
mTOR Signaling Pathway in Oncology Drug Pipeline Update 2014
3/25/2014 | published by: BioSeeker Group AB
mTOR Signaling Pathway in Oncology Drug Pipeline Update 2014 The mammalian target of rapamycin (mTOR) is an intracellular kinase that controls the production of proteins through its regulation of translational machinery. mTOR-activated proteins promote several hallmarks  |  read more...
$5,622.50
Analytical Tool - Cancer Immunotherapy
3/25/2014 | published by: BioSeeker Group AB
Analytical Tool - Cancer Immunotherapy Analytical Tool- Cancer Immunotherapy offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in immunotherapy drug development for the treatment of cancer. It is at  |  read more...
$20,437.50
2014 Strategies for the Italian Diagnostics Market
1/29/2014 | published by: Venture Planning Group
2014 Strategies for the Italian Diagnostics Market This new report from Venture Planning Group provides an overview of the Italian diagnostic testing market, including sales and market shares of leading  |  read more...
$4,850.00
2014 Strategies for the UK Diagnostics Market
1/29/2014 | published by: Venture Planning Group
2014 Strategies for the UK Diagnostics Market This new report from Venture Planning Group provides an overview of the UK diagnostic testing market, including sales and market shares of leading  |  read more...
$4,850.00